Human umbilical-cord-derived mesenchymal stem cells in combination with rapamycin reduce cartilage degradation via inhibition of the AKT/mTOR signaling pathway.
Immunopharmacology and immunotoxicology（2023）
摘要
Our study provides new evidence to support the use of hUMSCs in combination with rapamycin as a potential candidate for OA treatment.
更多查看译文
关键词
Human umbilical-cord-derived mesenchymal stem cells,combination therapy,mTOR signaling pathway,osteoarthritis,rapamycin
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要